Amarin Corp (AMRN)

• Market cap: $302M
• 1 day: -2.21%
• 5 days: -2.14%
• 1 month: -9.71%
• 3 months: 8.87%
• 6 months: 75.9%
• Year to date: 39.45%
• 1 year: 22.69%
• 5 years: -82.62%
• 10 years: -69.71%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Employees: 275

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

166% more call options, than puts

Call options by funds: $8.92M | Put options by funds: $3.35M

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

83% more capital invested

Capital invested by funds: $31.1M [Q1] → $57M (+$25.9M) [Q2]

16.7% more ownership

Funds ownership: 0.84% [Q1] → 17.54% (+16.7%) [Q2]

16% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 31

36% less funds holding

Funds holding: 140 [Q1] → 89 (-51) [Q2]

72% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 69

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $12
• Avg. target: $12
• High target: $12

1 analyst rating

• positive: 0 0%
• neutral: 0 0%
• negative: 1 100%

Goldman Sachs Paul Choi

$12

Sell Maintained

25 Jun 2025